Abstract
BackgroundThe preferred route of administering methotrexate is unclear. A recent cohort study in patients with early rheumatoid arthritis suggested improved treatment survival with subcutaneous methotrexate.ObjectivesTo determine the comparative drug survival...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
